Head-to-Head

AIM ImmunoTech Inc. vs. Repligen Corp

AIM

AIM ImmunoTech Inc.

$0.12 +0.50%

VS RGEN

Repligen Corp

$170.29 -1.38%

AIM ImmunoTech Inc. and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

AIMRGEN
Market Cap $4.79 million $11.04 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

AIMRGEN
Short Interest 0.24% 6.30%

AIM leads on 1 of 1 risk & sentiment factors.

Dig deeper: AIM overview, AIM financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.